M&A Deal Summary

NantOmics Acquires Genos Research

On April 13, 2017, NantOmics acquired information technology company Genos Research

Acquisition Highlights
  • This is NantOmics’ 1st transaction in the Information Technology sector.
  • This is NantOmics’ 2nd transaction in the United States.
  • This is NantOmics’ 1st transaction in California.

M&A Deal Summary

Date 2017-04-13
Target Genos Research
Sector Information Technology
Buyer(s) NantOmics
Deal Type Add-on Acquisition

Target

Genos Research

San Francisco, California, United States
Genos Research, Inc. is a platform for genomics research and discovery. The company's mission is to break down the barriers to accelerate disease research and medical cures. The Genos community democratizes access to comprehensive personal discovery through DNA, and empowers individuals to retain ownership of their genetic data and consent in the research process.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

NantOmics

Culver City, California, United States

Category Company
Founded 2012
Sector Information Technology
DESCRIPTION

NantOmics LLC is a provider of IT solutions to life science industry.


DEAL STATS #
Overall 2 of 2
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
State: California M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-10 OncoPlex Diagnostics

Rockville, Maryland, United States

OncoPlex Diagnostics is an accredited clinical laboratory focused on testing tumor cell proteins using mass spectrometry analysis.

Buy -